Development
The Cigna Group
CI
$317.40
$2.030.64%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -22.97% | -19.60% | 21.60% | 25.42% | 24.96% |
| Total Depreciation and Amortization | -2.42% | 5.60% | 2.95% | 4.77% | 3.11% |
| Total Amortization of Deferred Charges | 13.86% | -2.64% | -2.64% | -2.64% | -2.64% |
| Total Other Non-Cash Items | 108.03% | 89.38% | -1,122.78% | -745.97% | -597.33% |
| Change in Net Operating Assets | 497.26% | 42.74% | 275.69% | 28,330.77% | 166.97% |
| Cash from Operations | 36.47% | 14.89% | 33.45% | 43.38% | 20.37% |
| Capital Expenditure | -21.47% | -23.84% | -17.54% | -17.92% | -12.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -14,866.67% | -- | -- | -- |
| Divestitures | -99.73% | -99.79% | 4,268.64% | 4,264.41% | 8,026.23% |
| Other Investing Activities | -616.52% | -1,445.60% | -4,935.48% | -4,467.16% | 21.49% |
| Cash from Investing | -267.01% | -239.43% | 132.83% | 113.64% | 185.79% |
| Total Debt Issued | -- | 552.13% | 232.80% | 53.24% | -- |
| Total Debt Repaid | -15.94% | -69.43% | -881.56% | -1,327.53% | 45.71% |
| Issuance of Common Stock | -51.93% | -45.91% | -8.70% | 51.63% | 19.33% |
| Repurchase of Common Stock | 69.98% | 52.39% | 0.89% | -14.01% | 1.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.77% | -3.78% | -3.08% | -3.10% | -3.21% |
| Other Financing Activities | -493.67% | -863.93% | -636.62% | -389.66% | -429.17% |
| Cash from Financing | 61.80% | 48.25% | -20.03% | -43.81% | -36.87% |
| Foreign Exchange rate Adjustments | 118.60% | 111.97% | 102.54% | 6.45% | -32.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 342.52% | -54.66% | 660.16% | 253.43% | 108.36% |